Literature DB >> 25496308

B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells.

V Gorbacheva1, K Ayasoufi, R Fan, W M Baldwin, A Valujskikh.   

Abstract

Donor-reactive memory T cells undermine organ transplant survival and are poorly controlled by immunosuppression or costimulatory blockade. Memory CD4 T cells provide CD40-independent help for the generation of donor-reactive effector CD8 T cells and alloantibodies (alloAbs) that rapidly mediate allograft rejection. The goal of this study was to investigate the role of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in alloresponses driven by memory CD4 T cells. The short-term neutralization of BAFF alone or BAFF plus APRIL synergized with anti-CD154 mAb to prolong heart allograft survival in recipients containing donor-reactive memory CD4 T cells. The prolongation was associated with reduction in antidonor alloAb responses and with inhibited reactivation and helper functions of memory CD4 T cells. Additional depletion of CD8 T cells did not enhance the prolonged allograft survival suggesting that donor-reactive alloAbs mediate late graft rejection in these recipients. This is the first report that targeting the BAFF cytokine network inhibits both humoral and cellular immune responses induced by memory CD4 T cells. Our results suggest that reagents neutralizing BAFF and APRIL may be used to enhance the efficacy of CD40/CD154 costimulatory blockade and improve allograft survival in T cell-sensitized recipients. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Alloantibody; T cell biology; basic (laboratory) research; costimulation; immunobiology; science

Mesh:

Substances:

Year:  2014        PMID: 25496308      PMCID: PMC4304935          DOI: 10.1111/ajt.12984

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  37 in total

1.  Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival.

Authors:  Qiwei Zhang; Yifa Chen; Robert L Fairchild; Peter S Heeger; Anna Valujskikh
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

2.  Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.

Authors:  Hiroyuki Amano; Alice Bickerstaff; Charles G Orosz; Andrew C Novick; Hiroshi Toma; Robert L Fairchild
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

Review 3.  The impact of memory T cells on rejection and the induction of tolerance.

Authors:  Matthew O Brook; Kathryn J Wood; Nick D Jones
Journal:  Transplantation       Date:  2006-07-15       Impact factor: 4.939

Review 4.  BAFF, APRIL and their receptors: structure, function and signaling.

Authors:  Claudia Bossen; Pascal Schneider
Journal:  Semin Immunol       Date:  2006-08-17       Impact factor: 11.130

Review 5.  The role of APRIL and BAFF in lymphocyte activation.

Authors:  Pascal Schneider
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

6.  B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells.

Authors:  Lai Guan Ng; Andrew P R Sutherland; Rebecca Newton; Fang Qian; Teresa G Cachero; Martin L Scott; Jeffrey S Thompson; Julie Wheway; Tatyana Chtanova; Joanna Groom; Ian J Sutton; Cynthia Xin; Stuart G Tangye; Susan L Kalled; Fabienne Mackay; Charles R Mackay
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

7.  In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.

Authors:  Yifa Chen; Peter S Heeger; Anna Valujskikh
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

Review 8.  B cell immunobiology in disease: evolving concepts from the clinic.

Authors:  Flavius Martin; Andrew C Chan
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

9.  BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses.

Authors:  Qunrui Ye; Liqing Wang; Andrew D Wells; Ran Tao; Rongxiang Han; Anne Davidson; Martin L Scott; Wayne W Hancock
Journal:  Eur J Immunol       Date:  2004-10       Impact factor: 5.532

10.  TACI and BAFF-R mediate isotype switching in B cells.

Authors:  Emanuela Castigli; Stephen A Wilson; Sumi Scott; Fatma Dedeoglu; Shengli Xu; Kong-Peng Lam; Richard J Bram; Haifa Jabara; Raif S Geha
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

View more
  13 in total

1.  CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation.

Authors:  Katayoun Ayasoufi; Ran Fan; Robert L Fairchild; Anna Valujskikh
Journal:  J Immunol       Date:  2016-02-24       Impact factor: 5.422

2.  BAFF blockade prevents anti-drug antibody formation in a mouse model of Pompe disease.

Authors:  Phillip A Doerfler; Sushrusha Nayak; Roland W Herzog; Laurence Morel; Barry J Byrne
Journal:  Clin Immunol       Date:  2015-04-01       Impact factor: 3.969

Review 3.  T follicular helper cells in the generation of alloantibody and graft rejection.

Authors:  I Raul Badell; Mandy L Ford
Journal:  Curr Opin Organ Transplant       Date:  2016-02       Impact factor: 2.640

4.  IFN-γ production by memory helper T cells is required for CD40-independent alloantibody responses.

Authors:  Victoria Gorbacheva; Ran Fan; Xi Wang; William M Baldwin; Robert L Fairchild; Anna Valujskikh
Journal:  J Immunol       Date:  2014-12-29       Impact factor: 5.422

5.  Auto-immunity profile evaluation during different clinical manifestations of Behçet disease in Algerian patients: effect of corticosteroid treatment.

Authors:  Fatmazohra Djaballah-Ider; Abdelhamid Djaballah; Zineb Djeraba; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2019-02-05       Impact factor: 4.473

6.  Short-term Immunopathological Changes Associated with Pulse Steroids/IVIG/Rituximab Therapy in Late Kidney Allograft Antibody Mediated Rejection.

Authors:  Kenna R Degner; Nancy A Wilson; Shannon R Reese; Sandesh Parajuli; Fahad Aziz; Neetika Garg; Maha Mohamed; Tripti Singh; Didier A Mandelbrot; Sarah E Panzer; Robert R Redfield; Kristin Van Hyfte; Weixiong Zhong; Luis G Hidalgo; Arjang Djamali
Journal:  Kidney360       Date:  2020-05-28

Review 7.  Role of Memory T Cells in Allograft Rejection and Tolerance.

Authors:  Gilles Benichou; Bruno Gonzalez; Jose Marino; Katayoun Ayasoufi; Anna Valujskikh
Journal:  Front Immunol       Date:  2017-02-28       Impact factor: 7.561

8.  Measuring alloreactive B cell responses in transplant recipients.

Authors:  Suheyla Hasgur; Anna Valujskikh
Journal:  Curr Transplant Rep       Date:  2019-01-24

Review 9.  Role of Memory T Cells and Perspectives for Intervention in Organ Transplantation.

Authors:  Kailin Lin; Song Chen; Gang Chen
Journal:  Front Immunol       Date:  2015-09-14       Impact factor: 7.561

Review 10.  Follicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft Rejection.

Authors:  Yun-Hui Jeon; Youn Soo Choi
Journal:  Immune Netw       Date:  2016-08-23       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.